AGP Executive Report

Ebola Emergency: The DRC’s worst Ebola outbreak has reached 9,066 confirmed cases and 4,381 deaths, with 2,389 recoveries, across 65 health zones in seven provinces. Some areas are reporting fewer cases, but new hotspots persist and insecurity is hampering surveillance. No vaccine or treatment is specifically approved for the Bundibugyo strain; candidate vaccine trials are underway in Uganda. Children’s Health: Ebola is disrupting schooling for nearly 1.8 million children in eastern DRC. About 5,700 schools lack infection-prevention measures, and nearly 90% of pupils in affected areas have received no hygiene or sanitation support. Epidemic Preparedness: Congolese virologist Jean-Jacques Muyembe and epidemiologist Peter Piot received the 2026 Virchow Prize for decades of work on Ebola and epidemic response.

Ebola Outbreak: The DRC has recorded 9,066 cases and 4,381 deaths in its largest Ebola outbreak, with infections across 65 health zones in seven provinces. Ituri remains the epicenter. No vaccine is approved specifically for the Bundibugyo virus; candidate vaccine trials are underway in Uganda, while the DRC prepares a trial. Children at Risk: Ebola fears, weak hygiene facilities and inadequate infection controls are disrupting learning for nearly 1.8 million children across about 5,700 schools in affected areas, the Norwegian Refugee Council warns. Access to Care: A rehabilitated airstrip in Tshikapa has helped increase humanitarian flights from one to three a week, improving access to remote Kasai communities as funding cuts threaten the service. Health Leadership: Congolese virologist Jean-Jacques Muyembe and epidemiologist Peter Piot have received the 2026 Virchow Prize for decades of work on Ebola and epidemic preparedness.

Ebola Response: The Bundibugyo outbreak has killed 4,205 people among 8,728 confirmed cases as of Oct. 6, affecting 64 health zones across seven provinces. Cases are falling in Ituri and North Kivu, but new hotspots near South Sudan and gaps in surveillance remain concerns. Vaccine Research: Phase Ib trials of two candidate Bundibugyo vaccines have begun in Uganda. The DRC has received 70,000 doses of a vaccine not proven effective against this strain; nearly 7,800 frontline workers had received it by Oct. 7. Epidemic Preparedness: Kenya’s first Ebola death after travel from the DRC exposed weaknesses in regional border screening, as health officials traced contacts across the border. Congolese Health Leadership: Virologist Jean-Jacques Muyembe and epidemiologist Peter Piot received the 2026 Virchow Prize for decades of work on Ebola and epidemic preparedness. Care and Access: A report warns that blockade and insecurity around Minembwe are restricting civilians’ access to medicines and healthcare. Kinshasa’s Biamba Marie Mutombo Hospital, opened in 2007, remains a major healthcare project built through the late basketball star’s humanitarian mission. Urban Health: Kinshasa recorded an unhealthy air-quality reading of 193 on Thursday.

Ebola Response: The Bundibugyo outbreak has killed 4,205 people and caused 8,728 confirmed cases as of Oct. 6. Cases are falling in Ituri and North Kivu, but 47 affected health zones still report transmission, with new hotspots near South Sudan and insecurity hampering surveillance. Vaccine Trials: Oxford’s candidate vaccine has entered Phase Ib trials in Uganda, with a Moderna candidate also cleared for trials. No vaccine is specifically approved for Bundibugyo; 70,000 doses of the Zaire-strain vaccine Ervebo have reached the DRC, but its effectiveness against this outbreak is unproven. Public Health Leaders: Congolese virologist Jean-Jacques Muyembe and Belgian epidemiologist Peter Piot received the 2026 Virchow Prize for decades of work on Ebola and epidemic preparedness. Regional Screening: Kenya’s first Ebola death, in a traveler from the DRC, has raised concerns about border checks after he crossed multiple borders before diagnosis. Kinshasa Air: The city recorded an unhealthy air-quality index of 193, ranking third among the world’s most polluted cities in a Thursday morning reading.

Ebola Response: Cases have fallen in Ituri and North Kivu, but the outbreak remains severe: 8,728 confirmed cases and 4,205 deaths were reported by Oct. 6, with active transmission in 47 health zones and new hotspots near South Sudan. Insecurity and community resistance are hampering surveillance. Heart Health: A new Kinshasa study examines in-hospital deaths and heart ultrasound findings among patients hospitalized with congestive heart failure; its findings were not included in the available report. Vaccine Research: Phase Ib trials of two candidate vaccines for the Bundibugyo virus have begun in Uganda. No vaccine is specifically approved for this strain; the Ervebo doses given to DRC frontline workers target a different Ebola virus. Regional Alert: Kenya’s first Ebola death exposed gaps in cross-border screening. Officials are tracing 57 contacts, with some in quarantine and monitoring. Air Quality: Kinshasa recorded an air-quality index of 193, rated unhealthy.

Ebola Outbreak: Cases are declining in Ituri and North Kivu, but the outbreak remains severe: 8,728 confirmed cases and 4,205 deaths were reported by Oct. 6. New hotspots are emerging near South Sudan, and 47 of 64 affected health zones still report transmission. Insecurity and community resistance continue to hamper response efforts. Vaccine Research: Phase Ib trials of Oxford’s candidate vaccine for the Bundibugyo virus began in Uganda, with Moderna’s candidate also cleared for trials. The 70,000 Ervebo doses received by the DRC target a different Ebola strain and are not proven effective against this outbreak. Regional Screening: Kenya’s first Ebola death, in a traveller who had crossed borders from the DRC, has raised concerns about screening gaps. Authorities are tracing 57 contacts, with 10 in quarantine.

Ebola Update: Cases are declining in parts of the DRC, but the outbreak remains severe: authorities reported 8,728 confirmed cases and 4,205 deaths by Oct. 6. New hotspots are emerging near South Sudan, while insecurity and community resistance hamper tracking; 47 affected health zones still report active transmission. Vaccine Research: Phase Ib trials of Oxford’s Bundibugyo Ebola vaccine have begun in Uganda, with Moderna’s candidate also cleared for trials there. The 70,000 Ervebo doses received by the DRC target a different Ebola virus and have not been shown effective against Bundibugyo. Heart Health: A new Kinshasa study examines factors linked to in-hospital deaths and heart ultrasound findings among patients hospitalized with congestive heart failure; the available report does not include its results.

Ebola Outbreak: Cases are falling in parts of the DRC, but new hotspots—including near South Sudan—remain a concern. By Oct. 6, authorities had recorded 8,728 confirmed cases and 4,205 deaths. Insecurity and community resistance are hampering surveillance, so declines may not show the full picture. Vaccine Research: Phase Ib trials of an Oxford vaccine for the Bundibugyo strain began in Uganda on Oct. 6; a Moderna candidate has also received approval to begin trials. The DRC has received 70,000 doses of a vaccine not proven effective against this strain, with frontline workers receiving it under research and compassionate-use protocols. Regional Screening: Kenya’s first Ebola death after travel from the DRC exposed gaps in border checks. More than 50 contacts were being traced, highlighting how screening that relies on travellers’ disclosures can miss infections. Kinshasa Air Quality: The city recorded an unhealthy air-quality index of 193 on Thursday. Health Legacy: Dikembe Mutombo’s foundation helped establish the $29 million Biamba Marie Mutombo Hospital in Kinshasa, honoring his mother and expanding access to medical care.

Ebola Outbreak: New hotspots are emerging even as cases decline in some areas, WHO and Africa CDC warn. By Oct. 6, the Bundibugyo outbreak had caused 4,205 deaths among 8,728 confirmed cases across seven provinces. Forty-seven health zones still report transmission, while insecurity and community resistance are hampering surveillance. Vaccine Research: Phase Ib trials of Oxford’s candidate vaccine have begun in Uganda, with Moderna’s candidate also cleared for trials. The 70,000 Ervebo doses delivered to the DRC target a different Ebola strain, and their effectiveness against Bundibugyo is unproven. Regional Alert: Kenya’s first Ebola death has raised concerns about cross-border screening after the patient travelled from the DRC through Uganda to Nairobi. Kenyan authorities are tracing 57 contacts. Kinshasa Air Quality: The capital recorded an unhealthy air-quality index of 193, a level that can affect health, especially for sensitive groups.

Ebola Update: Transmission is easing in parts of Ituri and North Kivu, but new hotspots are emerging near South Sudan. By Oct. 6, the outbreak had caused 4,205 deaths among 8,728 confirmed cases; 47 of 64 affected health zones still reported active spread, with insecurity hampering surveillance. Vaccine Research: Phase Ib trials of Oxford’s Bundibugyo Ebola vaccine began in Uganda, with Moderna’s candidate also cleared for trials. No vaccine is approved specifically for this strain; the 70,000 Ervebo doses delivered to the DRC have not been proven effective against it. Regional Alert: Kenya’s first Ebola death after travel from the DRC via Uganda has exposed gaps in border screening. Officials identified 57 contacts, with 10 in quarantine. Kinshasa Air Quality: The city recorded an unhealthy air-quality index of 193 on Thursday, ranking third among the world’s most polluted cities.

Ebola Update: The outbreak has killed 4,205 people among 8,728 confirmed cases, but infections are declining in Ituri and North Kivu. Transmission remains active in 47 health zones, with new hotspots emerging near South Sudan and surveillance hampered by insecurity. Vaccine Trials: Phase Ib trials of Oxford’s Bundibugyo Ebola vaccine began in Uganda; Moderna’s candidate has also received ethical approval for trials. The DRC has received 70,000 doses of a vaccine not proven effective against this strain. Regional Alert: Kenya’s first Ebola death, in a traveller from the DRC, exposed gaps in border screening. Kenyan authorities are tracing more than 50 contacts. Air Quality: Kinshasa recorded an unhealthy AQI of 193, ranking third among the world’s most polluted cities in a Thursday morning reading.

Ebola Vaccine Research: Trials of two candidate vaccines against the Bundibugyo strain have begun in Uganda. The DRC has received 70,000 doses of the Ervebo vaccine, but it has not been proven effective against this strain. Outbreak Update: The DRC has reported 4,018 deaths among 8,300 cases across seven provinces. Officials say cases are declining in some areas, but Africa CDC warns that gaps in surveillance and insecurity could hide ongoing infections. Regional Alert: Kenya reported its first Ebola death after a traveller arrived from the DRC via Uganda. Health officials are tracing 57 contacts, highlighting concerns about border screening. Kinshasa Air Quality: The city recorded an AQI of 193, rated unhealthy, on Thursday morning.

Cross-Border Alert: Kenya reported its first Ebola death after a traveler from the DRC passed through Uganda and reached Nairobi with symptoms, raising questions about screening at borders and airports. Officials say 57 contacts have been identified; tracing is continuing. Ebola in the DRC: The Health Ministry says the outbreak has passed its peak, with 4,018 deaths among 8,300 confirmed cases and new infections declining in some areas. But Africa CDC and MSF warn that insecurity and gaps in surveillance could hide ongoing spread. Response and Care: Ten patients have recovered and left treatment centers in Beni. Kinshasa has set out a six-month response plan estimated at $1.2 billion and is seeking clearer accounting from aid partners; only about one in four of 97 organizations had submitted funding records. France has also pledged support.

Cross-Border Alert: Kenya’s first Ebola patient arrived from Beni via Uganda with symptoms and died two days later, exposing gaps in border and airport screening. Outbreak Watch: DRC officials say the epidemic has passed its peak, but the toll has topped 4,000 deaths among 8,300 confirmed cases. Africa CDC and MSF warn that falling case reports may reflect missed infections as insecurity disrupts surveillance; transmission remains active in parts of Ituri and North Kivu. Response Funding: The Health Ministry says about $99 million of $227 million mobilized for the response remains unused, and only a quarter of 97 partner organizations have accounted for funds received.

Ebola Update: DR Congo’s Health Ministry says the Ebola outbreak has passed its peak, with new cases declining after late-July highs, but transmission is still active in hotspots like Ituri and North Kivu; the country reports 4,018 deaths and 2,162 recoveries from 8,300 confirmed cases, while Africa CDC and MSF warn the drop may reflect surveillance gaps and insecurity. Funding & Accountability: Kinshasa says about $227 million has been mobilized for the first phase, but only 25% of 97 response partners have justified funds so far, and it warns partners may face coercive measures without accreditation. Frontline Disruption: MSF reports an Ebola response worker evacuated to the Netherlands after testing positive, underscoring ongoing risks for health staff. Conflict Pressure: Reports also highlight how fighting and attacks on displacement sites and transit centers are disrupting care and case detection. Public Health Planning: DRC presented a 180-day, $1.2 billion preparedness and response plan to keep surveillance, isolation, contact tracing, and community prevention running. Community Health Beyond Ebola: NBA Africa and Quest Water Global announced plans to build or renovate 55 basketball courts across the DRC by 2030, starting in Kinshasa, as a youth-focused wellness initiative.

Ebola Update (DRC): The Ministry of Health says the Ebola outbreak has passed its peak, with new cases declining and 19 of 63 health zones reporting no new cases for over 21 days, but it warns transmission is still active in hotspots in Ituri and North Kivu. Death Toll Tops 4,000: Latest figures put deaths at 4,018 from about 8,300 confirmed cases, with 2,162 recoveries; Médecins Sans Frontières and Africa CDC caution the real toll may be higher due to surveillance gaps and insecurity. Response Funding Crackdown: Kinshasa says only about 25% of 97 response partners have justified mobilized funds and warns partners may face coercive measures, with accreditation required to operate in the field. Frontline Disruptions: Reports describe displacement camp chaos, including a transit center burned during searches, and ongoing insecurity that keeps containment uneven. Community Health Signal: In Beni, 10 Ebola-positive patients were discharged after treatment, the first recoveries reported since the city’s resurgence. Health Beyond Ebola: NBA Africa and Quest Water Global announced plans to build or renovate 55 basketball courts in the DRC by 2030, starting in Kinshasa, as part of youth-focused community work.